Macrogenics, Inc.

59 patents currently held · Updated Nov 14, 2026

15 more in force are now held by other companies

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 2 name spellings.

Ending by 2030

Mar 2027

Next term end

When these terms end

5 yrs10 yrs20 yrs

Held patents by the year their term ends

20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.

2 fees due Dec 20 to 27, 2026 · next Dec 20
2 fees due Jan 9 to 11, 2027 · next Jan 9
1 fee due Feb 4, 2027
The maintenance fee for Fc region-containing polypeptides that exhibit improved effector function due to alterations of the extent of fucosylation, and methods for their use (US 9,096,877) comes due Feb 4, 2027. Unpaid by Aug 4, 2027, it lapses early.
3 fees due Apr 6 to 24, 2027 · next Apr 6
2 fees due May 19 to 21, 2027 · next May 19
1 fee due Jun 12, 2027
The maintenance fee for Methods of Using Bispecific Molecules Having Immunoreactivity with PD-1 and CTLA-4 (US 11,840,571) comes due Jun 12, 2027. Unpaid by Dec 13, 2027, it lapses early.
2 fees due Jul 2 to 30, 2027 · next Jul 2
4 fees due Sep 3 to 29, 2027 · next Sep 3
2 fees due Oct 28, 2027
1 fee due Nov 12, 2027
The maintenance fee for Multi-Chain Polypeptide-Containing Tri-Specific Binding Molecules (US 10,647,768) comes due Nov 12, 2027. Unpaid by May 12, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

1 of the patents on this record was granted since Aug 16, 2026
2 terms have ended since Aug 16, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Patent	Title	Status	Expires	Confidence
US 9,963,510	Covalent Diabodies and Uses Thereof In force Term ends Mar 18, 2027 · High confidence	In force	Term ends Mar 18, 2027	High confidence
US 11,098,125	FcgammaRIIB-Specific Antibodies and Methods of Use Thereof In force Term ends Jul 30, 2027 · High confidence	In force	Term ends Jul 30, 2027	High confidence
US 11,254,747	Covalent diabodies and uses thereof In force Term ends Dec 18, 2027 · From the USPTO record	In force	Term ends Dec 18, 2027	From the USPTO record
US 10,711,069	Methods for the treatment of disease using immunoglobulins having Fc regions with altered affinities for FcγRactivating and FcγRinhibiting In force Term ends Jun 8, 2028 · From the USPTO record	In force	Term ends Jun 8, 2028	From the USPTO record
US 9,284,375	Covalent Diabodies and Uses Thereof In force Term ends Aug 31, 2028 · High confidence	In force	Term ends Aug 31, 2028	High confidence
US 7,700,100	FcγRIIB fusion proteins and compositions thereof In force Term ends Nov 8, 2028 · From the USPTO record	In force	Term ends Nov 8, 2028	From the USPTO record
US 9,708,408	Methods for the treatment of disease using immunoglobulins having Fc Regions with altered affinities for FcγRactivating and FcγRinhibiting In force Term ends Jan 27, 2029 · From the USPTO record	In force	Term ends Jan 27, 2029	From the USPTO record
US 9,695,236	BCR-complex-specific antibodies and methods of using same In force Ends no later than Mar 25, 2029 · From the USPTO record	In force	Ends no later than Mar 25, 2029	From the USPTO record
US 10,479,831	BCR-complex-specific antibodies and methods of using same In force Ends no later than Mar 25, 2029 · From the USPTO record	In force	Ends no later than Mar 25, 2029	From the USPTO record
US 12,024,569	HER2/neu-Specific Antibodies and Methods of Using Same In force Term ends Mar 25, 2029 · High confidence	In force	Term ends Mar 25, 2029	High confidence

10 of 59 patents shown.

Pro members see all 59.

Pro members: see all 59 patents

Also on record, not counted in the 59: 15 patents in force now held by others · 64 lapsed for an unpaid fee · 27 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Export every term end as CSV · Pro

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

15 pending · 15 abandoned · 46 no status recorded

List them